Rare sugars are monosaccharides and their derivatives that occur in extremely small quantities in nature. Over 50 varieties of simple sugars are present, however, only seven of these sugars occur in large amounts, including L-arabinose, D-ribose, D-xylose, D-fructose, D-mannose, D-galactose, and D-glucose. Remaining are all rare sugar that have 70% of the sweetness of common sugar. Some rare sugars are used as building blocks to synthesize nucleoside analogues, which are used as antiviral and anticancer agents. They are prepared through organic procedures such as enzyme conversion or fermentation to make the identical compound. Despite their low natural abundance, rare sugars have tremendous potential in a several significant applications, including their utilization as components for antiviral medications. Moreover, they are used as low-calorie sweeteners, owing to their low glycemic index. In addition, they are used as anti-inflammatory agents due to immunosuppressive properties.
Factors such as rise in health awareness and increase in awareness about the benefits of rare sugar are expected to drive the growth of the global rare sugars market. As compared to traditionally used sugar, rare sugar offer several health benefits, which fuel their adoption among health-conscious consumers. However, use of synthetic chemical routes for manufacturing of rare sugars is economically not feasible, which hampers the growth of the market. Moreover, high cost of rare sugar restrains the market growth. On the contrary, increase in production capacity of rare sugar to meet the growing demand of consumers is expected to offer new growth opportunities to the rare sugars market.
The global rare sugars market is segmented into type, application, and region. According to type, the market is categorized into D-psicose, D-tagatose, D-allose, D-altrose, D-iditol, D-sorbose, and others. Among these, the D-allose is anticipated to account for highest revenue due to its various anti-oxidative, anti-inflammatory, antitumor, and immunosuppressant activities. Depending on application, the market is classified into sweetener, medicine, cosmetics, nutrition, food & flavor, and others. Rare sugars have vast application in medicine sectors, as they are used as building blocks to synthesize the nucleoside analogues, which are used as anticancer and antiviral agents.
Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key players operating in the global rare sugars market are DuPont de Nemours Inc., Sweet Cures, Douglas Laboratories, Sanwa Starch, Naturesupplies, Specom Biochemical, Matsutani Chemical Industry Co. Ltd., ASTRAEA Allulose, Specom Biochemical, and Hebei Huaxu. These players have been adopting various strategies such as acquisitions, partnerships, collaboration, joint ventures, agreements, expansions, and new product launches to create a strong consumer base in the rare sugars market.
KEY BENEFITS FOR STAKEHOLDERS
- The rare sugars market size has been analyzed across all regions.
- Porter’s five force analysis helps to analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.
- The report outlines the current market trends and future scenario of the market size to understand the prevailing opportunities and potential investment pockets.
- Major countries in the regions have been mapped according to their individual revenue contribution.
- The key drivers, restraints, and market opportunities and their detailed impact analysis are elucidated in the study.
- The rare sugars market analysis covers in-depth information of major industry participants.
Rare Sugars Market Report Highlights
Key Market Players
Matsutani Chemical Industry Co. Ltd., ASTRAEA Allulose, Naturesupplies, DuPont de Nemours Inc., Hebei Huaxu, Douglas Laboratories, Sweet Cures, Specom Biochemical, Sanwa Starch